Loading
DI
DiaMedica Inc. Stock: price and insider trades · Canada
DiaMedica Inc.: what insiders have been doing
Insider filings for DiaMedica Inc. are scarce in the SEDI feed, the latest one published on 29 June 2016. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 29 June 2016
Declarations4 total
53,000 shares@ CA$0.2041.6% of flowCommon SharesTSXSEDI:2857326
17,000 shares@ CA$0.2013.3% of flowCommon SharesTSXSEDI:2857328
30,000 shares@ CA$0.2023.5% of flowCommon SharesTSXSEDI:2857329
27,500 shares@ CA$0.2021.6% of flowCommon SharesTSXSEDI:2857327
4 of 4 declarations
About DiaMedica Inc.
DiaMedica Inc. is a biopharmaceutical company focused on developing treatments for kidney and neurological diseases. It is listed on the Toronto Stock Exchange under the symbol DM.
